I am a research scientist with expertise in modelling and simulation methods in the biomedical field. My focus is on population pharmacokinetic pharmacodynamic modelling (nonlinear mixed effects). I have applied population analysis to cardiovascular safety, environmental risk assessment, and cortisol replacement therapy. Throughout my early career, I have been privileged to work in diverse teams, collaborating on cross-disciplinary projects. This has required me to be highly flexible: to learn quickly; work efficiently; and communicate effectively, with team members from a range of backgrounds.
